Question 1

Am I eligible for this trial based on my treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection clinical trial (NCT00097799). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of tipranavir and ritonavir?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection clinical trial (NCT00097799). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to my current HIV medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection clinical trial (NCT00097799). Contact the study team or your healthcare provider for specific answers.

Question 4

What will my treatment schedule look like if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection clinical trial (NCT00097799). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any specific tests or monitoring I will need during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection clinical trial (NCT00097799). Contact the study team or your healthcare provider for specific answers.

Question 6

What support will be available to me during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection clinical trial (NCT00097799). Contact the study team or your healthcare provider for specific answers.

What this study is about